On April 8th, in a major move that signals growing momentum in value-based care for self-insured employers, Transcarent has officially completed its merger with Accolade, creating one of the largest independent, tech-enabled healthcare platforms in the U.S..

The two companies combined Transcarent’s AI-powered platform with Accolade’s expertise in personalized health advocacy, a comprehensive solution designed to simplify access, improve outcomes, and reduce costs for 2,000 employees and their families.

We welcomed Transcarent as a partner at our 2022 conference, where CEO Glen Tullman joined Jessica DaMassa for a compelling fireside chat exploring whether healthcare—or digital health—is in a bubble. Tullman explained the critical difference between valuations and value, emphasizing that while market sentiment can shift, the underlying need for better, more efficient care remains constant. Reflecting on the impact of the pandemic, Tullman pointed out that—despite its devastating consequences—it proved that digital health solutions can scale effectively.

DATE: April 8, 2025 | SOURCE: Transcarent

Join us and our global community of health innovators in Berlin on November 11-12, 2025.

Get your pass now!